Acrux is an Australian drug delivery business developing and commercialising a range of patient-preferred pharmaceutical products for global markets, using innovative, patented technology to administer drugs through the skin. Acrux's ACROSS, MDTS and Patchless Patch form a platform technology with applications for management of hormonal deficiencies, central nervous system disorders, contraception and dermotological conditions. The combination of the ACROSS, MDTS and Patchless Patch delivery method, with medically approved drugs form the basis of Acrux's pharmaceutical businesses.